AKBA · Akebia Therapeutics, Inc. · Documents
$0.68
-0.01 (-0.74%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$191.90M
Shares
277.11M
Volume · Oct 20
1.55M
Avg daily vol (3M)
6.72M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-10-14 | 2026-10-07 | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-08-05 | — | |
| 8-K | — | 2026-06-30 | — | |
| 8-K | — | 2026-06-22 | 2026-06-17 | |
| Investor Event Transcript | — | 2026-06-04 | 2026-06-30 | |
| 8-K | — | 2026-05-07 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| ARS | — | 2026-04-29 | 2025-12-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| DEF 14A | — | 2026-04-28 | — | |
| PRE 14A | — | 2026-04-15 | — | |
| 8-K | — | 2026-04-01 | 2026-03-27 | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 8-K | — | 2026-02-26 | — | |
| 8-K | — | 2026-01-30 | 2026-01-27 | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-12-01 | 2025-11-28 | |
| 8-K | — | 2025-11-17 | 2025-11-12 | |
| 10-Q | — | 2025-11-10 | 2025-09-30 | |
| 8-K | — | 2025-11-10 | — | |
| 8-K | — | 2025-10-28 | — | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | — | |
| 8-K | — | 2025-06-13 | 2025-06-10 | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| 8-K | — | 2025-05-08 | — | |
| ARS | — | 2025-04-29 | — | |
| DEFA14A | — | 2025-04-29 | — | |
| DEF 14A | — | 2025-04-29 | — | |
| 8-K | — | 2025-03-20 | 2025-03-19 | |
| 10-K | — | 2025-03-13 | 2024-12-31 | |
| 8-K | — | 2025-03-13 | — | |
| 8-K | — | 2025-02-07 | 2025-02-03 | |
| 8-K | — | 2025-01-13 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-11-07 | — | |
| 8-K | — | 2024-10-22 | — | |
| 8-K | — | 2024-10-16 | 2024-10-15 | |
| S-3 | — | 2024-09-03 | — | |
| 8-K | — | 2024-08-08 | — | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-07-11 | 2024-07-10 | |
| 8-K | — | 2024-06-24 | 2024-06-21 | |
| 8-K | — | 2024-06-10 | 2024-06-06 | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| ARS | — | 2024-04-25 | 2023-12-31 | |
| DEF 14A | — | 2024-04-25 | — | |
| DEFA14A | — | 2024-04-25 | — |
Showing 1–50 of 181 filings
Key facts
CIK
1517022
CUSIP
00972D105
13F (30d)
17 filings
17 filers
Visit website
Investor relations